XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - CAD ($)
$ in Millions
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating activities    
Earnings $ 1,517 $ 4,913
Adjustments to reconcile earnings to net cash provided by operating activities:    
Depreciation and amortization 2,766 2,526
Deferred income tax (recovery)/expense (82) 983
Changes in unrealized (gain)/loss on derivative instruments, net 200 (1,005)
Earnings from equity investments (805) (1,159)
Distributions from equity investments 1,145 1,442
Impairment of equity investments 2,351 0
Impairment of long-lived assets 0 105
Other 222 51
Changes in operating assets and liabilities 213 (451)
Net cash provided by operating activities 7,527 7,405
Investing activities    
Capital expenditures (3,790) (3,928)
Long-term investments and restricted long-term investments (413) (1,018)
Distributions from equity investments in excess of cumulative earnings 438 285
Additions to intangible assets (154) (136)
Proceeds from dispositions 265 0
Loans to affiliates, net 10 (232)
Net cash used in investing activities (3,644) (5,029)
Financing activities    
Net change in short-term borrowings 71 245
Net change in commercial paper and credit facility draws 231 3,365
Debenture and term note issues, net of issue costs 4,834 2,553
Debenture and term note repayments (3,517) (2,994)
Contributions from noncontrolling interests 21 10
Distributions to noncontrolling interests (232) (194)
Common shares issued 3 18
Preference share dividends (284) (287)
Common share dividends (4,920) (4,480)
Redemption of preferred shares held by subsidiary 0 (300)
Other (52) (60)
Net cash used in financing activities (3,845) (2,124)
Effect of translation of foreign denominated cash and cash equivalents and restricted cash (22) (17)
Net increase in cash and cash equivalents and restricted cash 16 235
Cash and cash equivalents and restricted cash at beginning of period 676 637
Cash and cash equivalents and restricted cash at end of period $ 692 $ 872